The authors describe a simple, solid-phase chemiluminescence immunoassay for the measurement of estradiol-17β in extracts of peripheral venous plasma. The method has similar sensitivity, specificity, precision, and accuracy to a conventional radioimmunoassay with a tritiated antigen. An immunoglobulin G fraction of monoclonal antibodies to estradiol-6-carboxymethyl oxime-bovine serum albumin is passively adsorbed onto the walls of polypropylene tubes. The labeled antigen is estradiol-6-carboxymethyl oxime-aminobutylethyl isoluminol. After the binding reaction (1 hr at 22 °C), the solution is removed by aspiration and the antibody-bound fraction is washed once with buffer (400 μL). Sodium hydroxide (5 mol/L, 300 μL) is added and the mixture incubated for 30 min at 37 ° C. Luminescence is initiated by oxidation of the label with microperoxidase/hydrogen peroxide and the signal integrated for 10 s. The light yield is inversely proportional to the concentration of estradiol in the standard or sample.
CITATION STYLE
Kim, J. B., Barnard, G. J., Collins, W. P., Kohen, F., Lindner, H. R., & Eshhar, Z. (1982). Measurement of plasma estradiol-17β by solid-phase chemiluminescence immunoassay. Clinical Chemistry, 28(5), 1120–1124. https://doi.org/10.1093/clinchem/28.5.1120
Mendeley helps you to discover research relevant for your work.